Urinary CA19-9 Level in the Differential Diagnosis of Neurogenic and Non-Neurogenic Lower Urinary Tract Dysfunction in Children
The Value of Urinary CA19-9 Level in the Differential Diagnosis of Neurogenic and Non-Neurogenic Lower Urinary Tract Dysfunction in Children
Sponsor: Marmara University
A NA clinical study on Lower Urinary Track Symptoms, this trial is ongoing. The trial is conducted by Marmara University and has accumulated 3 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Feb 2026 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Feb 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
First recorded
Jan 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Marmara University
For direct contact, visit the study record on ClinicalTrials.gov .